Nomos IPO To Support Expanded Radiation Therapy Applications
This article was originally published in The Gray Sheet
Executive Summary
Nomos will pursue expanded indications for its IMRT Intensity Modulated Radiation Therapy technology for cancerous tumors with proceeds from a planned initial public offering, valued at up to $50 mil